PMGC Holdings Inc. (ELAB)
NASDAQ (CM) NASDAQ (CM) Primary Summary
ELAB Chart
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company
Acquisition Target Specializes in High-Precision Electrical and Mechanical Assembly, Including Printed Circuit Board Manufacturing for Commercial and Industrial Customers Across the U.S.A. PMGC's second pending acquisition since April, demonstrates that its M&A strategy is well underway, with additional deals expected this year.
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
NEWPORT BEACH, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”) today announced that it has filed its Quarterly Report on Form 10-Q (“Quarterly Report”) for the three months ended March 31, 2025, with the U.S. Securities and Exchange Commission (“SEC”).
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
NEWPORT BEACH, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital,” “we,” “our,” or “us”), a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced its planned filing of a Schedule 13D with the U.S. Securities and Exchange Commission disclosing beneficial ownership of common stock in Alaunos Therapeutics, Inc. (Nasdaq: TCRT).
PMGC Holdings Inc. Dividends
PMGC Holdings Inc. Earnings
PMGC Holdings Inc. (ELAB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has PMGC Holdings Inc. ever had a stock split?
PMGC Holdings Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Graydon Bensler C.F.A. CEO | NASDAQ (CM) Exchange | US73017P2011 ISIN |
| US Country | 2 Employees | - Last Dividend | 10 Mar 2025 Last Split | - IPO Date |
Overview
Elevai Labs Inc. is a prominent skincare development company that focuses on the design, manufacture, and marketing of advanced skincare products within the United States. Initially established as Reactive Medical Labs Inc., the company underwent a rebranding to Elevai Labs, Inc. in December 2021, a strategic move to better align with its mission and the innovative nature of its offerings. Since its inception in 2020, Elevai Labs has been headquartered in Newport Beach, California, from where it orchestrates its operations with an aim to serve a specific segment of the skincare market. This includes dermatologists, plastic surgeons, medical spa owners, and physicians who specialize in aesthetic and therapeutic skincare solutions. Through its dedication to innovation and quality, Elevai Labs Inc. has positioned itself as a trusted partner for professionals seeking effective post-skincare procedure care serums.
Products and Services
- Empower Post-Skincare Procedure Care Serum:
- Enfinity Post-Skincare Procedure Care Serum:
This serum is meticulously designed for the face, neck, and upper chest regions, providing targeted care and recovery support following skincare procedures. Empower serum is acclaimed for its potent formula that aids in enhancing the skin's natural healing processes, thereby ensuring optimal results post-procedure.
Similar to the Empower serum, Enfinity is also crafted for application on the face, neck, and upper chest areas. It is specially formulated to complement the recovery phase of skin following various aesthetic interventions. Enfinity serum stands out for its innovative ingredients that work to restore, rejuvenate, and maintain the skin’s health and appearance, post-procedure.
Contact Information
